Report cover image

Lactic Acid Market Size, Share & Trends Analysis Report By Raw Material (Corn, Sugarcane, Cassava, Yeast Extract), By Application (Pharmaceuticals, Personal Care, Industrial, Food & Beverages, Polylactic Acid), By Region, And Segment Forecasts, 2026 - 203

Publisher Grand View Research
Published Dec 10, 2025
Length 150 Pages
SKU # GV20723783

Description

Lactic Acid Market Summary

The global lactic acid market size was estimated at USD 3,682.4 million in 2025 and is projected to reach USD 6,653.7 million by 2033, growing at a CAGR of 7.7% from 2026 to 2033. Growing consumer and regulatory push toward sustainable materials is accelerating the adoption of lactic acid as a key building block for bioplastics, cosmetics, and food ingredients.

Its versatility across end-use industries is strengthening its market penetration, while manufacturers scale production capacities to meet expanding global demand. The rising focus on clean-label and functional nutrition is boosting lactic acid utilization as a preservative, acidity regulator, and flavor enhancer. As brands shift toward natural formulation frameworks, lactic acid’s safety profile and multifunctionality are positioning it as a preferred ingredient across premium food and beverage categories.

Surging global investments in PLA-based bioplastic production are opening high-value opportunities for lactic acid manufacturers. Strategic collaborations, downstream integration, and capacity expansions can enable players to capture rising demand from packaging, 3D printing, and sustainable materials markets.

Global Lactic Acid Market Report Segmentation

This report forecasts volume & revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2033. For this study, Grand View Research has segmented the global lactic acid market report based on raw material, application, and region:
  • Raw Material Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2033)
  • Corn
  • Sugarcane
  • Cassava
  • Yeast Extract
  • Other Crops
  • Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2033)
  • Industrial
  • Food & Beverages
  • Beverages
  • Bakery & Confectionary Products
  • Dairy Products
  • Meat Products
  • Other Food Products
  • Pharmaceuticals
  • Personal Care
  • Polylactic Acid
  • Other Applications
  • Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Component Segment
1.2.2. Technology Segment
1.2.3. Application Segment
1.2.4. End Use
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Artificial Intelligence in Drug Repurposing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising demand for cost-effective drug development,
3.2.1.2. Increasing clinical trials in drug repurposing
3.2.1.3. Growing focus on precision medicine and targeted drug development
3.2.2. Market restraint analysis
3.2.2.1. Highly regulated industry
3.2.2.2. High computational costs and infrastructure requirements
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Case Study Insights
3.4. Artificial Intelligence in Drug Repurposing Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
3.4.2.6. Social Landscape
Chapter 4. Artificial Intelligence in Drug Repurposing Market: Component Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Artificial Intelligence in Drug Repurposing Market Component Movement Analysis
4.3. Global Artificial Intelligence in Drug Repurposing Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
4.4. Software & Platforms
4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Services
4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Artificial Intelligence in Drug Repurposing Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Artificial Intelligence in Drug Repurposing Market Technology Movement Analysis
5.3. Global Artificial Intelligence in Drug Repurposing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
5.4. Machine Learning/Deep Learning
5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. Natural Language Processing (NLP)
5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.6. Knowledge Graphs & Network-Based AI
5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.7. Generative AI & Large Language Models (LLMs)
5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.8. Computer Vision
5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Artificial Intelligence in Drug Repurposing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Artificial Intelligence in Drug Repurposing Market Application Movement Analysis
6.3. Global Artificial Intelligence in Drug Repurposing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Oncology
6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Neurology
6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Cardiology
6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.7. Infectious Diseases
6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.8. Rare & Orphan Diseases
6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.9. Other Therapeutic Areas
6.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. Artificial Intelligence in Drug Repurposing Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Artificial Intelligence in Drug Repurposing Market End Use Movement Analysis
7.3. Global Artificial Intelligence in Drug Repurposing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. Contract Research Organizations (CROs)
7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.6. Academic & Research Institutes
7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.7. Others
7.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 8. Artificial Intelligence in Drug Repurposing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework
8.4.1.3. Competitive scenario
8.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework
8.5.1.3. Competitive scenario
8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework
8.6.1.3. Competitive scenario
8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework
8.7.1.3. Competitive scenario
8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework
8.8.1.3. Competitive scenario
8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2025
9.4. Company Profiles/Listing
9.4.1. BostonGene Corporation
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. BenevolentAI
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Innophore
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Delta4.ai
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. BioXcel Therapeutics Inc.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. BullFrog AI Holdings, Inc.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Graphwise
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Owkin, Inc
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Insilico Medicine
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Healx
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us